Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Glaukos Corporation (GKOS) Profit Margins

Over the twelve months to 2026-06-30, Glaukos Corporation (GKOS) had gross margin 60.7%, operating margin -31.6%, net margin -30.7%, free cash flow margin -2.0%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GKOSGlaukos CorporationFollow GKOS — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
10.6B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 3 days
LineFY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin81.9%85.9%86.8%86.2%83.7%59.2%77.3%75.6%76.0%75.5%55.7%60.7%
Operating margin-14.4%3.7%-1.4%-7.2%-21.2%-54.9%-11.2%-29.1%-40.9%-31.9%-39.3%-31.6%
Net margin-51.9%4.0%-0.1%-7.1%6.5%-53.5%-16.9%-35.1%-42.8%-38.2%-37.0%-30.7%
FCF margin-4.3%5.3%12.4%4.7%-2.1%-13.3%-7.8%-22.4%-24.8%-17.6%-7.7%-2.0%

USD billions · SEC XBRL

Glaukos Corporation — questions

What is Glaukos Corporation's gross margin?
60.7% over the twelve months to 2026-06-30.
What is Glaukos Corporation's operating margin?
-31.6% over the twelve months to 2026-06-30.
What is Glaukos Corporation's net profit margin?
-30.7% over the twelve months to 2026-06-30.

Every figure on this page comes from Glaukos Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.